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translocation into the nucleus early in infection, and actin polymerization within the nucleus late 23 in infection coincident with viral replication. Of the six viral factors that are sufficient, when 24 coexpressed, to induce the nuclear localization of actin, only AC102 is essential for viral 25 replication and the nuclear accumulation of actin. We therefore sought to better understand the 26 role of AC102 in actin mobilization in the nucleus early and late in infection. Although AC102 27 was thought to function early in infection, we found that AC102 is predominantly expressed as a 28 late protein. In addition, we observed that AC102 is required for F-actin assembly in the nucleus 29 during late infection, as well as for proper formation of viral replication structures and 30 nucleocapsid morphogenesis. Finally, we found that AC102 is a nucleocapsid protein and a 31 newly recognized member of a complex consisting of the viral proteins EC27, C42, and the actin 32 polymerization protein P78/83. Taken together, our findings suggest that AC102 is necessary for 33 nucleocapsid morphogenesis and actin assembly during late infection through its role as a 34 component of the P78/83-C42-EC27-AC102 protein complex. 35 36 IMPORTANCE 37
The baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) is an 38 important biotechnological tool for protein expression and cell transduction, and related 39 3 nucleopolyhedroviruses are also employed as environmentally benign insecticides. One impact 40 of our work is to better understand the fundamental mechanisms through which AcMNPV 41 exploits the cellular machinery of the host for replication, which may aid in the development of 42 improved baculovirus-based research and industrial tools. Moreover, AcMNPV's ability to 43 mobilize the host actin cytoskeleton within the cell's nucleus during infection makes it a 44 powerful cell biological tool. It is becoming increasingly clear that actin plays important roles in 45 the cell's nucleus, yet the regulation and function of nuclear actin is poorly understood. Our 46 work to better understand how AcMNPV relocalizes and polymerizes actin within the nucleus 47 may reveal fundamental mechanisms that govern nuclear actin regulation and function, even in 48 the absence of viral infection. 49 INTRODUCTION 6 therefore began by determining the temporal expression profile of AC102 by Western blotting 96 over a range of times post infection with the wild-type AcMNPV strain WOBpos (9), using a 97 polyclonal antibody we generated that specifically recognizes AC102 (Fig. 1A) . Surprisingly, at 98 0, 8, and 10 hpi, no detectable AC102 was present. Expression of AC102 was first detected at 12 99 hpi and protein continued to accumulate through 36 hpi. The timing of AC102 expression 100 matched that of VP39, the major capsid protein and a tightly regulated late factor (20) . 101
To confirm the lack of detectable AC102 expression during the early phase of infection, 102
prior to the initiation of DNA replication, infected cells were treated with aphidicolin, a drug that 103 inhibits DNA synthesis and thus prevents the early to late transition. No AC102 was detected by 104
Western blotting after aphidicolin treatment (Fig. 1B) . These data indicate that ac102 is 105 predominantly expressed as a late gene. 106
The AC102-K66A mutation results in 10-fold reduced viral titers and small plaques 107
Given that AC102 is predominantly expressed late in infection, we next sought to 108 investigate the late function(s) of AC102. Because ac102 is an essential gene (14, 21), it is not 109 possible to produce a virus carrying a deletion mutation. Therefore, we generated ten mutant 110 viruses carrying one of the following point mutations in AC102: N47A, T53A, A55V, D61A, 111 K66A, S77A, A80V, L96A, L105A, or N114A. These amino acid residues were chosen because 112 they are highly conserved between orthologs of AC102 in diverse alphabaculoviruses (Fig. 2) . 113
Growth of the mutants was initially assessed by infecting cells at MOI of 10 and then measuring 114 viral titer at 18 or 48 hpi ( Table 1) . One virus, containing the AC102-D61A mutation, did not 115 produce any detectable progeny, suggesting this mutation causes inviability. Most other mutants 116 exhibited modest 2-to 5-fold reductions in viral titer compared with WOBpos at one or both 117 time points. The AC102-K66A mutant virus, in contrast, produced 10-fold fewer BV progeny 118 7 than WOBpos at both time points, and was chosen for further analysis. In a more comprehensive 119 one-step growth curve, the AC102-K66A mutant produced 10-fold fewer progeny at 18, 24, 36, 120 and 48 hpi ( Fig. 3A, left) . To assess whether the AC102-K66A mutation was the cause of the 121 growth defect, an AC102-K66A-rescue virus was generated by inserting a wild-type copy of 122 ac102 into the bacterial replication cassette in the AC102-K66A bacmid (9). The growth kinetics 123 of the AC102-K66A-rescue virus were indistinguishable from those of WOBpos (Fig. 3A, right) . 124
Thus, the AC102-K66A mutation causes a 10-fold reduction in BV progeny production 125 throughout the late phase of infection. 126
In addition to the replication defect, the AC102-K66A mutant virus produced plaques 127 that were 6-fold smaller than those produced by WOBpos or AC102-K66A-rescue ( Fig. 3B) . 128
These small plaques typically consisted of only one or a few infected cells (Fig. 3C) . The small 129 plaques suggest that the AC102-K66A mutation results in a reduced capacity to spread from cell 130 to cell. 131
The AC102-K66A mutation results in lower AC102 expression 132
To further investigate the nature of the defect caused by the AC102-K66A mutation, we 133 compared the relative levels of wild-type AC102 and mutant AC102-K66A protein over the 134 course of infection using Western blotting ( Fig. 4A, B ). For both, initial expression was observed 135 at 12 hpi. However, at all time points tested, the levels of AC102-K66A were significantly 136 reduced compared with wild-type AC102 (Fig. 4B) . These results indicate that the AC102-K66A 137 mutation does not affect the onset of AC102 expression, but results in lower protein levels, likely 138 by impacting the translation or stability of AC102. 139
We also observed the effect of the AC102-K66A mutation on the abundance and 140 localization of AC102 in infected cells by immunofluorescence microscopy. At 12 hpi, AC102 141 8 was not visible in WOBpos or AC102-K66A-infected cells ( Fig. 4C, D) . At 24 and 36 hpi, 142
WOBpos-infected cells showed strong AC102 signal in the nucleus, particularly in and around 143 the VS (identified by a region of intense staining of viral DNA). In contrast, most AC102-K66A-144 infected cells showed reduced levels of AC102 in the nucleus with staining that was often 145 limited to a thin outline of the VS at 24 and 36 hpi ( Fig. 4C, D) . Thus, the AC102-K66A 146 mutation causes a reduction of AC102 and a redistribution to the periphery of the VS. 147
AC102 promotes a condensed virogenic stroma and is important for nucleocapsid assembly 148
To further elucidate the roles of AC102 in the nucleus, we examined the effect of the 149 AC102-K66A mutation on nuclear organization and nucleocapsid assembly. We initially noted 150 that in AC102-K66A-infected cells, the VS appeared to be less condensed than that of WOBpos-151 infected cells, with the structure taking up almost the entire nucleus ( Fig. 4D) . To confirm the 152 effect of AC102-K66A on the VS, we performed immunofluorescence microscopy using an 153 antibody against PP31, a delayed early protein and VS marker (22). The timing of PP31 154 expression appeared similar in WOBpos and AC102-K66A-infected cells ( Fig. 5A, C) . At 12 155 hpi, only dim PP31 signal could be detected in the nuclei of both AC102-K66A and WOBpos-156 infected cells ( Fig. 5A) . At 24 and 36 hpi, PP31 was localized to the condensed VS in WOBpos-157 infected cells, and to a less condensed VS in AC102-K66A-infected cells. At both time points, 158 PP31 was also less abundant in the VS in AC102-K66A-infected cells compared with WOBpos-159 infected cells. These results confirm that the AC102-K66A mutation results in an aberrant and 160 decondensed VS structure. 161
We also investigated the effect of AC102-K66A on the expression and localization of the 162 major capsid protein VP39. As with PP31, the timing of VP39 expression appeared unaffected in 163 the AC102-K66A mutant (Fig. 5B, D) . At 12 hpi, VP39 showed punctate localization to the VS 164 9 both in WOBpos and AC102-K66A-infected cells ( Fig. 5B) . At 24 hpi, however, when 165
WOBpos-infected cells continued to show punctate or diffuse VP39 localization in the VS, the 166 majority of AC102-K66A-infected cells had VP39 in the RZ, where it often assembled into long 167 filaments. At 36 hpi, VP39 redistributed to a punctate localization in the RZ in WOBpos-infected 168 cells, whereas it remained filamentous in the ring zone of most AC102-K66A-infected cells. We 169 quantified VP39 distributions in WOBpos and AC102-K66A-infected cells by dividing cells into 170 three phenotypic classes: (1) wild type with punctate distribution in the VS or RZ, (2) 171 "filamentous" with long thin filaments in the RZ, and (3) "cable-like" with thick VP39 cables in 172 the RZ ( Fig. 5E) . At 24 and 36 hpi, the majority of WOBpos-infected cells had wild-type VP39 173 distribution, whereas the majority of AC102-K66A-infected cells had a filamentous phenotype, 174 and only AC102-K66A-infected cells contained cable-like VP39 structures. Thus, the AC102-175 K66A mutation causes aberrant assembly of VP39 into filamentous structures late in infection. 176
We used transmission electron microscopy (TEM) to further compare intranuclear 177 structures in WOBpos and AC102-K66A-infected cells. At 24 hpi, WOBpos-infected cells 178 showed a condensed VS, composed of electron-dense lobes, and a peripheral RZ, both of which 179 contained nucleocapsids ( Fig. 6A, B) . In contrast, AC102-K66A-infected cells lacked a well-180 defined VS, instead containing a more amorphous region that occupied most of the nucleus and 181 did not contain electron-dense lobes or visible nucleocapsids ( Fig. 6C) . Moreover, in AC102-182 K66A-infected cells, the peripheral RZ was densely packed with long tubular structures that 183 were variable in length and were often bundled or clustered ( Fig. 6D-F) . The tubules also varied 184 in electron density, with some being nearly electron-lucent and others having electron-dense 185 areas indicating the packaging of viral DNA (Fig. 6E, F) . Taken together with the VP39 186 localization studies, these results suggest that the tubular structures are aberrant assemblies of 187 10 VP39 that are not properly formed into unit-length nucleocapsids, and are instead assembled into 188 long tubular structures that sometimes contain viral DNA. 189
AC102 is crucial for nuclear actin polymerization in the ring zone late in infection 190
Our previous work suggested that AC102 is required for nuclear actin polymerization, as The AC102-K66A mutation results in a defect in polyhedrin expression and polyhedra 202 formation 203
We also investigated a possible function for AC102 very late in infection by assessing the 204 timing and expression of the very late protein polyhedrin in WOBpos-infected and AC102-205 K66A-infected cells by Western blotting (Fig. 8A, B) . At 18 hpi there was no detectable 206 expression of polyhedrin, as expected for a very late protein. At 24 hpi, WOBpos-infected cells 207 showed strong expression of polyhedrin, whereas AC102-K66A-infected cells showed very little 208 expression. At 36 hpi, polyhedrin expression was significantly higher in WOBpos-infected cells 209 than in AC102-K66A-infected cells. To assess whether lower polyhedrin expression also 210 11 correlated with fewer polyhedra, we imaged infected cells at 36 hpi using TEM and counted the 211 fraction with at least one polyhedron ( Fig. 8C, D) . Compared with WOBpos-infected cells, 212 significantly fewer AC102-K66A-infected cells contained polyhedra. Together, these data 213 indicate that perturbing AC102 function impacts the proper timing of polyhedrin expression and 214 the formation of polyhedra during the transition to very late stage infection. 215
AC102 is a nucleocapsid protein that interacts with P78/83, C42, and EC27 216
The timing of AC102 expression as a late gene and the effect of the AC102-K66A 217 mutation on nucleocapsid morphogenesis suggested that AC102 may be a structural component 218 of the nucleocapsid. To test whether AC102 is a virion-associated protein, BV particles were 219 isolated via ultracentrifugation over a sucrose cushion, then fractionated into their envelope and 220 nucleocapsid components. Western blotting revealed that AC102 is associated with the 221 nucleocapsid fraction, but not with the envelope fraction ( Fig. 9A) . These results indicate that 222 AC102 is a structural component of nucleocapsids. 223
As a nucleocapsid structural component, AC102 would be predicted to interact with other 224 capsid proteins. To identify the specific viral proteins with which AC102 interacts, a virus was 225 constructed that expresses AC102 fused to a Twin-Strep-tag (23) in the native ac102 locus of the 226 viral genome. The AC102-Strep virus grows at a rate that is indistinguishable from WOBpos 227 ( Fig. 9B) , indicating that the AC102-Strep protein is fully functional. To purify AC102 with 228 interacting proteins, Sf9 cells were infected with AC102-Strep or WOBpos as a control, and at 229 24 hpi cells were lysed and AC102-Strep protein was isolated by Strep-Tactin affinity 230 chromatography. Interestingly, AC102-Strep co-purified with three prominent viral proteins that 231 were identified by SDS-PAGE and mass spectrometry of isolated gel bands as EC27, C42, and 232 P78/83 ( Fig. 9C) , which were previously found to interact with one another in a complex (16).
12
Furthermore, comparative mass spectrometry of AC102-Strep elution samples revealed that 234 AC102 and these three proteins were the most abundant viral proteins in the pulldown ( Table 2) . 235
Other less abundant proteins identified in the pulldown (E25, E18, VP39, and VP80) were also 236 identified as virion-associated proteins by mass spectrometry (24-26). Taken together, these 237 results indicate that AC102 is a nucleocapsid protein that specifically interacts in a complex with 238 the other nucleocapsid proteins P78/83, C42, and EC27. 239
240

DISCUSSION 241
AcMNPV protein AC102 was previously shown to be essential for viral replication (14, 242 21), sufficient to induce nuclear localization of actin (NLA) when expressed with five other viral 243 NLA genes (13), and necessary for NLA (14). Although AC102 was thought to be expressed 244 early in infection (13), here we reveal a role for AC102 as a late-expressed nucleocapsid protein 245 that is a component of the P78/83-C42-EC27-AC102 complex and is crucial for VS organization, 246 nucleocapsid morphogenesis, and nuclear F-actin assembly. 247
Our findings demonstrate that AC102 is expressed predominantly late in infection, with 248 detectable protein first observed at 12 hpi. The onset of AC102 expression is consistent with the 249 onset of ac102 mRNA accumulation, which begins at 12 hpi and peaks at 18 hpi based on 250 transcriptomics studies (27). AC102 protein levels continue to accumulate through at least 36 251 hpi, suggesting that mRNA and protein levels may not be directly correlated at later time points. 252
The onset of AC102 expression is similar to that of VP39, which is strictly expressed late in 253 infection (20). Furthermore, AC102 expression is undetectable after treating cells with 254 aphidicolin, which prevents late gene expression. Thus, ac102 is predominantly expressed as a 255 late gene. 256
13
Many late viral proteins are structural components of virions, and our data indicate that 257 AC102 associates with BV nucleocapsids, but not with their envelopes. Furthermore, we find 258 that AC102 interacts in a stable complex with the nucleocapsid proteins P78/83, C42, and EC27, 259 which were previously shown to interact with one another (16). AC102 had not, however, been 260 recognized as a member of this complex. The associations between P78/83, C42, and EC27 were 261 discovered through yeast-two-hybrid studies, which rely on the interaction of bait and prey 262 proteins fused with domains from a transcription factor. We have found that AC102 is not 263 functional when fused at its N-terminus or C-terminus with larger proteins (unpublished 264 observations), offering a possible explanation as to why interactions with AC102 may have been 265 missed in two-hybrid assays. 266
A previous analysis of AC102 function relied on the characterization of an AcD102 267 mutant following bacmid transfection, which does not result in the production of viral progeny 268 (14), thus precluding a thorough assessment of the role of AC102 throughout infection. Our 269 characterization of the AC102-K66A partial loss-of-function mutant virus alleviates this issue 270 and has revealed new roles of AC102 during late infection. We found that AC102 is important 271 for establishing and/or maintaining a condensed VS, as this structure was expanded and 272 amorphous in AC102-K66A-infected cells. This is similar to what has been seen in cells treated 273 with cytochalasin D (10), a drug that inhibits actin polymerization and also induces proteolysis 274 of the genome packaging protein p6.9 (28). AC102 is also important for nucleocapsid 275 showing VP39 mislocalized into filaments and cables in the RZ of AC102-K66A infected cells. 284
Taken together, these data confirm that AC102 is important for proper organization of viral 285 replication structures and nucleocapsid morphogenesis, most likely due to its role as a structural 286 component of nucleocapsids. 287
Our observations indicate that, in cells infected with the AC102-K66A mutant, 288 expression of the very late protein polyhedrin is also delayed and reduced, and fewer infected 289 cells contain polyhedra as compared with WOBpos-infected cells. This phenotype is similar to 290 that recently observed for a virus carrying a point mutation in VP39 (VP39-G276S), which 291 exhibits reduced expression of polyhedrin and fewer polyhedra (36). It was suggested that lower 292 polyhedrin expression in the VP39-G276S mutant might result from the sequestration of viral 293 DNA in aberrant tubular nucleocapsid-like structures, and a similar phenomenon may account 294 for the phenotype of the AC102-K66A mutant. 295 Consistent with observations from cells transfected with an AcD102 mutant bacmid (14), 296
we also observed decreased levels of nuclear F-actin in late stage AC102-K66A-infected cells. 297 AC102's association with the P78/83-containing complex suggests a mechanism through which 298 AC102 may impact actin polymerization in the nucleus. P78/83 is a viral a mimic of host 299
Wiskott-Aldrich Syndrome protein (WASP) family proteins (15) that activates the host Arp2/3 300 complex to promote actin polymerization (9). It is required for both actin-based motility during 301 early infection (12) and nuclear F-actin polymerization during late infection (9). The defect in 302 15 nuclear actin polymerization seen for the AC102-K66A mutant virus could therefore be caused 303 by perturbed stability, localization or actin polymerization activity of the P78/83-C42-EC27-304 AC102 complex. Consistent with this notion, deletion of c42/ac101 also causes a reduction in 305 nuclear F-actin (37). Furthermore, because nuclear F-actin is required for progeny production (7-306 11), the reduced nuclear F-actin accumulation caused by the AC102-K66A mutation may in part 307 account for reduced production of BV. 
Viral growth curves and plaque size measurements 369
To compare the kinetics of progeny BV production for WOBpos, AC102-K66A, AC102-370 K66A-rescue, and AC102-Strep viruses, one-step growth curves were performed in triplicate 371 using an immunoplaque assay (41). To measure plaque size, images of plaques were captured on 372 an Olympus IX71 microscope with a 20x objective (Olympus LUCPlanFL, 0.45 NA), 373
CoolSNAP HQ camera (Photometrics), and µManager software (42). The Fiji distribution of 374 ImageJ (43) was used to measure the area of individual plaques. 375
Budded virus purification and fractionation 376
To obtain purified BV, Sf9 cells were infected with WOBpos at an MOI of 10 and cell 377 culture supernatant containing BV was collected at 2 dpi. The supernatant was then overlaid onto 378 a 40% sucrose cushion and centrifuged at 100,000 x g for 1 h at 15˚C using a Beckman SW-28 379 rotor in a Beckman L8-M ultracentrifuge to pellet BV particles. BV was then resuspended in 10 380 mM Tris buffer (pH 8.5). To further fractionate BV into envelope and nucleocapsid components, 381 NP-40 was added to 100 µg of BV at a final concentration of 1%, incubated for 1 h at 4˚C, and 382 the sample was centrifuged at 80,000 x g for 1 h at 15˚C using a Beckman TLA-100 rotor in a 383
Beckman TL-100 ultracentrifuge to separate the supernatant fraction containing viral envelope 384 proteins from the pellet fraction containing nucleocapsid-associated proteins. The nucleocapsid 385 fraction was then washed and centrifuged a second time under identical conditions to ensure that 386 there was no contamination from the envelope fraction. 387
Purification and identification of AC102 interacting proteins 388
To purify AC102-Strep together with interacting proteins, Sf9 cells were infected with 389 AC102-Strep or control WOBpos viruses at an MOI of 10, and infected cells were harvested at 390 24 hpi. Cells were lysed on ice for 10 min in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1 391 mM EDTA, 1% Triton X-100, 1 µg/ml LPC, 1 µg/ml aprotinin, and 1 mM PMSF) and 392 centrifuged in a microcentrifuge at 16,000 x g for 2 min at room temperature to separate nuclei 393 and cellular debris from the cytoplasmic supernatant. The clarified cell lysate was incubated with 394 19 50 µl (packed volume) of Strep-Tactin Sepharose resin (IBA Lifesciences) for 2 h at 4˚C with 395 rotation. Beads were washed with lysis buffer containing 300 mM NaCl, and protein was eluted 396 with lysis buffer containing 6 µM D-desthiobiotin (IBA Lifesciences). Protein concentration was 397 assessed via Bradford assay. Samples containing equal amounts of protein were separated by 398 SDS-PAGE, and gels were stained with SimplyBlue SafeStain (Thermo Fisher Scientific) 399 according to the manufacturer's maximum sensitivity protocol. 400
For identification of individual proteins visualized by SDS-PAGE, bands that were 401 unique to the AC102-Strep pulldown were cut out, in-gel digested with trypsin (44), and 402 subjected to mass spectrometry as described below. In addition, for the bulk identification of 403 eluted proteins, whole elution samples from three independent affinity chromatography 404 experiments for both AC102-Strep and control WOBpos were trypsin digested and subjected to 405 mass spectrometry as described below. 406 (5% acetonitrile/ 0.02% heptaflurobutyric acid (HBFA)). The column was then directly coupled 411 to an electrospray ionization source mounted on a Thermo-Fisher LTQ XL linear ion trap mass 412
spectrometer. An Agilent 1200 HPLC delivering a flow rate of 300 nl/min was used for 413 chromatography. Peptides were eluted using an 8-step MudPIT procedure (45). The buffers used 414 were: buffer A (above); buffer B (80% acetonitrile/ 0.02% HBFA); buffer C (250 mM 415 ammonium acetate/ 5% acetonitrile/ 0.02% HBFA); and buffer D (500 mM ammonium acetate/ 416 5% acetonitrile/ 0.02% HBFA). This protocol was also followed for proteins originating from gel 417 20 bands, except that the nano LC column was packed with 10 cm of Polaris c18 5 µm only, and the 418 chromatography consisted of a simple gradient from 100% buffer A to 40% buffer A, 60% buffer 419
B. 420
Protein identification and quantification were done with Integrated Proteomics Pipeline 421 IP2 software (Integrated Proteomics Applications) using ProLuCID/Sequest (46), DTASelect 422 (47, 48), and Census (49). Tandem mass spectra were extracted into ms1 and ms2 files from raw 423 files using RawExtractor (50). Data was searched against the AcMNPV (NC_001623.1) 424 translated protein database, supplemented with sequences of common contaminants, and 425 concatenated to a decoy database in which the sequence for each entry in the original database 426 was reversed (51). LTQ data was searched with 3000.0 milli-amu precursor tolerance, and the 427 fragment ions were restricted to a 600.0 ppm tolerance. All searches were parallelized and 428 searched on the VJC proteomics cluster. Search space included all fully tryptic peptide 429 candidates with no missed cleavage restrictions. Carbamidomethylation (+57.02146) of cysteine 430 was considered a static modification. We required 1 peptide per protein and both trypitic termini 431 for each peptide identification. The ProLuCID search results were assembled and filtered using 432 the DTASelect program with a peptide false discovery rate (FDR) of 0.001 for single peptides 433 and a FDR of 0.005 for additional peptides for the same protein. The estimated false discovery 434 rate was about 1% for the datasets used. To better distinguish direct from indirect interactions in 435 whole elution samples, we used Spotlite (52), a web-based platform designed to identify specific 436 protein-protein interactions from affinity purified samples subjected to mass spectrometry. We 437 used the HGSCore scoring algorithm (53) within Spotlite to identify high confidence 438
interactions with a p-value of p < 0.05. Sciences). Anti-AC102 serum was passed over the AC102 affinity resin, and antibodies were 463 eluted with 100 mM glycine pH 2.5. Antibodies were immediately neutralized to pH 7.5 by 464 adding 1 M Tris pH 8.8 and stored at -20°C or -80°C in 50% glycerol. 465
Analysis of AC102 and AC102-K66A expression by Western blotting 466
To observe AC102 protein expression over the course of infection, Sf9 cells were 467 infected in triplicate with WOBpos at an MOI of 10 and infected cells were harvested at 0, 8, 10, 468 12, 14, 16, and 36 hpi. Cells were lysed on ice for 10 min in lysis buffer (50 mM Tris-HCl, pH 469 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 µg/ml LPC, 1 µg/ml aprotinin, and 1 mM 470 PMSF) and centrifuged in a microcentrifuge at 16,000 x g for 2 min at room temperature to 471 separate nuclei and cellular debris from the cytoplasmic supernatant. Cell lysates were subjected 472 to SDS-PAGE, with equal loading of total protein in all lanes (as determined by Bradford assay). 473
Proteins were transferred to nitrocellulose membranes, and probed by Western blotting using: 474 rabbit anti-AC102; mouse-anti-VP39 antibody P10C6 (54) (kindly provided by JaRue Manning); 475 and rabbit-anti-cofilin antibody GA15 as a loading control (kindly provided by Michael 476
Goldberg and Kris Gunsalus). To assess whether AC102 is expressed late in infection following 477 the onset of DNA replication, cells were infected as above in the presence of either 5 µg/ml 478 aphidicolin or DMSO (as a control). At 24 hpi, cells were lysed and subjected to SDS-PAGE and 479
Western blotting as described above using rabbit-anti-AC102 and rabbit-anti-cofilin antibodies. 480
To compare expression levels of AC102 and other proteins in WOBpos and AC102-481 K66A-infected cells, Sf9 cells were infected in triplicate as described above, and lysed at 0, 6, 482 12, 18, 24, and 36 hpi. Cell lysates were prepared and subjected to SDS-Page and Western 483 blotting as described above using: anti-AC102; rabbit-anti-polyhedrin (55) (generously provided 484 by Loy Volkman); and anti-cofilin. 485 23
Immunofluorescence microscopy 486
For immunofluorescence microscopy, Sf21 cells were seeded onto CELLSTAR black-487 walled 96-well plates with micro-clear bottoms (Grenier Bio-One) to ~75% confluency and 488 infected in triplicate with WOBpos or AC102-K66A virus at an MOI of 10. At 12, 24, or 36 hpi, 489 cells were fixed with 4% paraformaldehyde in PHEM buffer (60 mM PIPES, pH6.9, 25 mM 490 HEPES, 10 mM EGTA, 2 mM MgCl 2 ), permeabilized in PHEM with 0.15% Triton X-100, 491 blocked in PHEM with 5% normal goat serum (MP Biomedicals) + 1% BSA, and processed for 492 immunofluorescence staining as described previously (14). Primary antibodies used were: anti-493 AC102, 1:500 dilution in PHEM buffer; anti-VP39 P10C6, 1:200; or rabbit-anti-PP31, 1:200 494 (22) (kindly provided by Linda Guarino). Phalloidin conjugated to Alexa Fluor 488 or 568 at a 495 1:400 dilution in PHEM buffer (Molecular Probes) was used to visualize F-actin and 500 µg/ml 496 Hoechst was used to visualize DNA. 497
Cells were imaged with an Opera Phenix High Content Screening System (PerkinElmer) 498 using its confocal spinning disk mode with either 20x water immersion objective (PerkinElmer, 499 NA 1.0, WD 1.7 mm) or 63x water immersion objective (PerkinElmer, NA 1.15, WD 0.6 mm) 500 and the system's two sCMOS cameras (4.4-megapixel 2100x2100, 16-bit resolution, 6.5µm pixel 501 size). Image analysis was carried out using Harmony High-Content Imaging and Analysis 502 Software (PerkinElmer) on 16-bit images. All analysis was done using maximum intensity 503 projections except for nuclear and cytoplasmic actin quantification, which was done on single z-504 plane images through the center of cell nuclei. 505
Electron microscopy 506
Sf9 cells were infected in triplicate with WOBpos or AC102-K66A virus at an MOI of 10 507 and infected cells were fixed at 18 and 36 hpi for 45 min with 1.5% paraformaldehyde and 2.0% 508 24 glutaraldehyde in 0.05 M sodium cacodylate buffer, pH 7.3. Cell pellets were embedded in 2% 509 agarose, rinsed three times in 0.05 M sodium cacodylate buffer, pH 7.3, and postfixed in a 510 solution of 1% osmium tetroxide, 1.6% potassium ferricyanide, and 0.1 M sodium cacodylate 511 buffer, pH 7.2. Postfixed samples were then embedded in resin, sectioned, and stained with 2% 512 uranyl acetate in 70% methanol, rinsed in decreasing concentrations of methanol, and stained 513 with Reynolds lead citrate. Samples were imaged with a FEI Tecnai 12 transmission electron 514 microscope (Thermo Fisher Scientific) equipped with a 3072 x 3072 pixel Rio 9 CMOS camera 515 (Gatan). 516
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